# Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment

> **NCT06805994** · PHASE1 · RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 175 (estimated)

## Conditions studied

- Staphylococcal Aureus Infection
- Microbial Colonization
- Pediatric Infection
- S. Aureus Colonization
- Microbial Transplant

## Interventions

- **BIOLOGICAL:** Nasal Microbiota Transplant (NMT)
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT06805994
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-27
- **Primary completion:** 2027-09-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 175 (ESTIMATED)
- **Last updated:** 2025-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06805994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06805994, "Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06805994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*